TOKYO -- The Tokyo Metropolitan Government plans to conduct clinical trials of the anti-parasitic drug Ivermectin at metropolitan and public hospitals to assess its effectiveness against COVID-19, Nikkei has learned.
Coronavirus
Tokyo considers trials of parasite drug for COVID-19
Ivermectin tablets to be assessed for possible home use
